Earticle

초록

영어

This study selected 38 Korean pharmaceutical firms listed on the KOSPI and KOSDAQ and attempted to evaluate their management efficiency on the last five years of data from 2007 to 2011. In order to utilize DEA(Data Envelopment Analysis) model, this study used output data such as net profit, operating profit, and gross sales and input variables such as sales management expenses, R&D cost, labor cost, and total assets. A Malmquist model, a measurement method of productivity, was used to evaluate the dynamic change of the management efficiency of five years. Because an efficiency analysis preceded drawing a Malmquist Productivity Index(MPI) for analyzing productivity, the current research is comprised of both efficiency and productivity analysis. The result analyzed by a DEA technique showed that domestic pharmaceutical firms increased their efficiency and productivity through internal management innovation, maintaining efficient size relatively. Although domestic pharmaceutical firms’ productivity is affected more by technological changes than by efficiency changes, efficiency changes in individual pharmaceutical firms are not affected by technological changes. Thus, individual pharmaceutical firms stick to short-term efficiency. Accordingly, because investment expansion of R&D and facilities for improving long-term productivity rather increases input by decreasing efficiency, it is for individual pharmaceutical firms to perform this strategy.

목차

Ⅰ. 서론
 Ⅱ. 국내 제약기업 현황
 Ⅲ. 효율성의 이론적 배경
 Ⅳ. 연구설계
 Ⅴ. 경영효율성 분석
 Ⅵ. 결론
 참고문헌
 Abstract

키워드

저자

• 박정석 [ Jeong Seok Park | 삼진제약 원료생산부 관리과 팀장 ] 주저자
• 유인선 [ In-Seon Yoo | 수원대학교 경영학과 교수 ] 교신저자

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  생산성연구: 국제융합학술지 [Productivity Research: An International Interdisciplinary Journal]

• 간기

  격월간

• pISSN

  1225-3553

• 수록기간

  1987~2025

• 등재여부

  KCI 등재

• 십진분류

  KDC 325 DDC 330